These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 28284220)
1. Serum microRNA profiling in patients with glioblastoma: a survival analysis. Zhao H; Shen J; Hodges TR; Song R; Fuller GN; Heimberger AB Mol Cancer; 2017 Mar; 16(1):59. PubMed ID: 28284220 [TBL] [Abstract][Full Text] [Related]
2. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma. Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080 [TBL] [Abstract][Full Text] [Related]
3. Analysis of Serum miRNA in Glioblastoma Patients: CD44-Based Enrichment of Extracellular Vesicles Enhances Specificity for the Prognostic Signature. Tzaridis T; Reiners KS; Weller J; Bachurski D; Schäfer N; Schaub C; Hallek M; Scheffler B; Glas M; Herrlinger U; Wild S; Coch C; Hartmann G Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003586 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208 [TBL] [Abstract][Full Text] [Related]
5. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma. Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475 [TBL] [Abstract][Full Text] [Related]
6. Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Zhi F; Shao N; Wang R; Deng D; Xue L; Wang Q; Zhang Y; Shi Y; Xia X; Wang S; Lan Q; Yang Y Neuro Oncol; 2015 Mar; 17(3):383-91. PubMed ID: 25140035 [TBL] [Abstract][Full Text] [Related]
7. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients. Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437 [TBL] [Abstract][Full Text] [Related]
8. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients. Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966 [TBL] [Abstract][Full Text] [Related]
9. miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma. Khalil S; Fabbri E; Santangelo A; Bezzerri V; Cantù C; Di Gennaro G; Finotti A; Ghimenton C; Eccher A; Dechecchi M; Scarpa A; Hirshman B; Chen C; Ferracin M; Negrini M; Gambari R; Cabrini G Oncotarget; 2016 May; 7(19):28195-206. PubMed ID: 27057640 [TBL] [Abstract][Full Text] [Related]
10. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes. Gulluoglu S; Tuysuz EC; Sahin M; Kuskucu A; Kaan Yaltirik C; Ture U; Kucukkaraduman B; Akbar MW; Gure AO; Bayrak OF; Dalan AB Brain Res; 2018 Dec; 1700():199-210. PubMed ID: 30176243 [TBL] [Abstract][Full Text] [Related]
12. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475 [TBL] [Abstract][Full Text] [Related]
14. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer. Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related]
16. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer. Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306 [TBL] [Abstract][Full Text] [Related]
17. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma. Chen J; Yang L; Wang X Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of candidate microRNAs in gastric cancer: A validation study. Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528 [TBL] [Abstract][Full Text] [Related]
19. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study. Rahmati Y; Alivand M; Mollanoori H Comput Biol Chem; 2021 Jun; 92():107458. PubMed ID: 33761401 [TBL] [Abstract][Full Text] [Related]
20. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer. Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]